Neurocrine Biosciences
NBIX
#1484
Rank
A$21.70 B
Marketcap
A$213.49
Share price
0.22%
Change (1 day)
3.50%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Stock price history for Neurocrine Biosciences (NBIX)

Highest end of day price: A$258.22 AUD on 2026-07-30

Lowest end of day price: A$2.78 AUD on 2009-11-12

Stock price history of Neurocrine Biosciences from 1996 to 2026

Annual Stock Price Performance

Year Performance
2026 8.14%
2025 2.88%
2024 3.62%
2023 9.73%
2022 35.01%
2021-11.16%
2020-11.50%
2019 53.36%
2018-9.95%
2017 100.70%
2016-26.07%
2015 147.68%
2014 133.93%
2013 14.74%
2012-12.51%
2011 10.82%
2010 184.01%
2009-16.82%
2008-29.20%
2007-55.79%
2006-83.61%
2005 27.97%
2004-11.17%
2003 20.11%
2002-9.71%
2001 59.41%
2000 31.84%
1999 260.00%
1998-17.29%
1997-17.65%
1996-20.00%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
A$39.77 2.15%๐Ÿ‡บ๐Ÿ‡ธ USA
A$369.98 0.48%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1,717-1.06%๐Ÿ‡บ๐Ÿ‡ธ USA
A$252.91 0.04%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.01879-33.50%๐Ÿ‡บ๐Ÿ‡ธ USA
A$105.30 2.00%๐Ÿ‡บ๐Ÿ‡ธ USA
A$14.44 2.07%๐Ÿ‡บ๐Ÿ‡ธ USA
A$86.40 1.21%๐Ÿ‡ฌ๐Ÿ‡ง UK